Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • QBench Reviews & Ratings
    4.6 out of 5 stars 153 Ratings
    Company Website for QBench
  • Lockbox LIMS Reviews & Ratings
    4.8 out of 5 stars 72 Ratings
    Company Website for Lockbox LIMS
  • Qualio Reviews & Ratings
    4.4 out of 5 stars 919 Ratings
    Company Website for Qualio
  • Bright Data Reviews & Ratings
    4.4 out of 5 stars 1,461 Ratings
    Company Website for Bright Data
  • Google Cloud BigQuery Reviews & Ratings
    4.5 out of 5 stars 2,037 Ratings
    Company Website for Google Cloud BigQuery
  • Filejet Reviews & Ratings
    4.8 out of 5 stars 54 Ratings
    Company Website for Filejet
  • SDS Manager Reviews & Ratings
    5.0 out of 5 stars 4 Ratings
    Company Website for SDS Manager
  • ChatD&B Reviews & Ratings
    Company Website for ChatD&B
  • IONOS Cloud Object Storage Reviews & Ratings
    4.6 out of 5 stars 45,199 Ratings
    Company Website for IONOS Cloud Object Storage
  • AthenaHQ Reviews & Ratings
    4.9 out of 5 stars 41 Ratings
    Company Website for AthenaHQ

What is Scilligence RegMol?

RegMol, developed by Scilligence, serves as an all-encompassing database tailored for the registration of entities and bioassays, catering to a diverse range of entities. This intuitive platform streamlines the centralized handling of protocols and assay details, significantly improving collaboration on research and development initiatives. By utilizing our powerful data mining capabilities, which include searches based on chemical structures, HELM, and biosequences, RegMol equips researchers with the tools they need to make insightful, data-informed choices. We are firm believers in the idea that collaborative efforts yield the best outcomes, which inspired us to create a resource that facilitates knowledge and resource sharing among peers globally. Acknowledging the hurdles of managing the extensive datasets crucial for pioneering discoveries, our electronic lab notebook (ELN) offers a flexible web-based environment for efficiently organizing and retrieving unstructured data. Furthermore, our advanced search and indexing functions empower researchers to navigate through large volumes of unstructured information, guaranteeing that critical insights are captured. Ultimately, our mission is to transform the research landscape by ensuring that data is readily available and actionable for all participants, thereby fostering a more innovative and efficient scientific community. With this aim, we continuously enhance our offerings to better serve the needs of researchers everywhere.

What is BenevolentAI?

BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Not specified

Customer Service / Support

Standard Support
Web-Based Support

Training Options

Not specified

Training Options

Documentation Hub
Online Training

Company Facts

Organization Name

Scilligence

Date Founded

2001

Company Location

United States

Company Website

www.scilligence.com

Company Facts

Organization Name

BenevolentAI

Date Founded

2013

Company Location

Luxembourg

Company Website

www.benevolent.com

Categories and Features

Life Sciences

Not specified

Categories and Features

AI Science

Not specified

Drug Discovery

Not specified

Life Sciences

Not specified

Popular Alternatives

Signals VitroVivo Reviews & Ratings

Signals VitroVivo

PerkinElmer Informatics

Popular Alternatives

Scitara DLX Reviews & Ratings

Scitara DLX

Scitara